Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | VHL | P40337 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24760234 | 0.77 | FOLH1 (0.43) | TSHRMEN1KMT2AFAAHMAPK1 | |
| SCHEMBL14355656 | 0.77 | FOLH1 (0.43) | TSHRMEN1KMT2AFAAHMAPK1 | |
| SCHEMBL2608299 | 0.75 | TSHR (0.46) | TSHRMEN1KMT2AFAAHMAPK1 | |
| SCHEMBL6343473 | 0.74 | MEN1 (0.46) | TSHRMEN1KMT2AFAAHMAPK1 | |
| SCHEMBL21273032 | 0.72 | — | — | |
| SCHEMBL6728568 | 0.72 | — | — | |
| SCHEMBL5692283 | 0.72 | MAPK1 (0.45) | TSHRMEN1KMT2AFAAHMAPK1 | |
| SCHEMBL6724603 | 0.72 | — | — | |
| SCHEMBL6724599 | 0.72 | — | — | |
| SCHEMBL5907620 | 0.72 | MAPK1 (0.45) | TSHRMEN1KMT2AFAAHMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10323127-B2 | Poly(aspartic acid) derived co-polymers for a controlled release of perfuming ingredients | FIRMENICH SA (CH) | 2019-06-18 | — | — | US | disclosed |
| US-20180016396-A1 | POLY(ASPARTIC ACID) DERIVED CO-POLYMERS FOR A CONTROLLED RELEASE OF PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2018-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10323127-B2 | Poly(aspartic acid) derived co-polymers for a controlled release of perfuming ingredients | PHGDH, PARG, ACLY | TSHR 4874/4885MEN1 4024/4885KMT2A 3471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.